Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Professional Diagnostics Market - Analysis, Technologies & Forecasts to 2020 - Growing Focus on Diagnosing Life-threatening Conditions - Research and Markets

Research and Markets
Posted on: 15 Nov 16

Research and Markets has announced the addition of the "Global Professional Diagnostics Market 2016-2020" report to their offering.

The report forecasts the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years.

One of latest trends in the market is launch of novel tests in lung and colon cancer influencing the market growth of PD devices. Targeted genetic testing for cancer that is available to molecular pathologists is a unique combination of ease of use, cost-effectiveness, reliability, and sensitivity. Multiplexed assays reduce the cost and turnaround time compared with existing methods by allowing the user to simultaneously analyze the relevant oncogenes. The two test panels help in personalizing treatment and improving patient care with rapid analysis of clinically actionable mutations occurred in lung and colon cancer.

Key vendors:

  • Abbott Diagnostics
  • Danaher
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by end-user

Part 08: Geographical segmentation

Part 09: Market drivers

Part 10: Impact of drivers

Part 11: Market challenges

Part 12: Impact of drivers and challenges

Part 13: Market trends

Part 14: Vendor landscape

Part 15: Key vendor analysis

Part 16: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/hlgj58/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20161115005990/en/

Business Wire
www.businesswire.com

Last updated on: 15/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.